AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Based on the 15-minute chart, Ligand Pharmaceuticals has recently experienced a "death cross" in both the MACD and KDJ indicators, as of December 4, 2022, at 3:45pm. This suggests that the stock price has the potential to continue declining and indicates a shift in momentum towards the downside, with a potential for further price decreases.
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet